Association between adiponectin levels and coronary heart disease and mortality: a systematic review and meta-analysis

Adiponectin and Risk of Coronary Heart Disease in Apparently Healthy Men and Women (from the EPIC-Norfolk Prospective Population Study)

(2011) Mélanie Côté et al.   AMERICAN JOURNAL OF CARDIOLOGY

Adiponectin resistance and vascular dysfunction in the hyperlipidemic state

(2010) Rong Li et al.   ACTA PHARMACOLOGICA SINICA

Adipokines as novel biomarkers and regulators of the metabolic syndrome

(2010) Yingfeng Deng et al.   Annals of the New York Academy of Sciences

Association of serum adiponectin with risk for cardiovascular events in patients with peripheral arterial disease

(2010) Grazina Urbonaviciene et al.   ATHEROSCLEROSIS

Mechanisms of adiponectin regulation and use as a pharmacological target

(2010) Susan A Phillips et al.   CURRENT OPINION IN PHARMACOLOGY

Value of adiponectin as predictor of 5-year all-cause mortality in patients with symptomatic peripheral arterial disease: Results from the Linz Peripheral Arterial Disease (LIPAD) study

(2009) Benjamin Dieplinger et al.   CLINICA CHIMICA ACTA

Association of adiponectin with mortality in older adults: the Health, Aging, and Body Composition Study

(2009) J. Poehls et al.   DIABETOLOGIA

Adipocytokines and the risk of coronary heart disease in healthy middle aged men: the PRIME Study

(2009) G Luc et al.   INTERNATIONAL JOURNAL OF OBESITY

Adiponectin Levels and Risk of Type 2 Diabetes

(2009) Shanshan Li et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Plasma Adiponectin Level and Myocardial Infarction: the JMS Cohort Study

(2009) Yu Hatano et al.   JOURNAL OF EPIDEMIOLOGY

High-molecular-weight adiponectin does not predict cardiovascular events in patients with type 2 diabetes

(2009) Katarzyna Krzyzanowska et al.   Translational Research

Association of adiponectin with adverse outcome in coronary artery disease patients: results from the AtheroGene study

(2008) R. Schnabel et al.   EUROPEAN HEART JOURNAL

Leptin, but not adiponectin, is a predictor of recurrent cardiovascular events in men: results from the LIPID study

(2008) S Söderberg et al.   INTERNATIONAL JOURNAL OF OBESITY

Prognostic Value of Adiponectin for Cardiovascular Disease and Mortality

(2008) Jacqueline M. Dekker et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Adiponectin and Risk of Coronary Heart Disease in Older Men and Women

(2008) Jorge R. Kizer et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM